NCT03058783View on ClinicalTrials.gov

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

May 12, 2020

Study Completion Date

May 12, 2020

Conditions
Atopic Dermatitis
Interventions
DRUG

IDP-124 Lotion

IDP-124 Lotion, twice-daily application

DRUG

IDP-124 Vehicle Lotion

IDP-124 Vehicle Lotion, twice-daily application

Trial Locations (1)

94536

Valeant Site 05, Fremont

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT03058783 - Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects | Biotech Hunter | Biotech Hunter